HIMS — Hims & Hers Health Share News
0.000.00%
Last trade - 00:00- $6.85bn
- $7.38bn
- $2.35bn
Hims & Hers Health swings to Q1 net loss on restructuring charges, GLP-1 strategic pivot
Hims & Hers raises 2026 revenue forecast
Brief: Hims & Hers Nominates Kofi Amoo-Gottfried To Its Board Of Directors
U.S. STOCKS ON THE MOVE-Eli Lilly, Compass Pathways, Charter Communications
U.S. STOCKS ON THE MOVE-Zoom, Compass Pathways, X-Energy
U.S. STOCKS ON THE MOVE- Charter Communications, Gentex, Moog
U.S. STOCKS ON THE MOVE-Texas Instruments, World Kinect, Procter & Gamble
Hims & Hers Health rises after J.P. Morgan initiates coverage with 'overweight' rating
U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems
Hims & Hers says it has steady estrogen patch supply amid US shortages (updated)
Hims & Hers expands into menopause care as estrogen patch demand rises
U.S. STOCKS ON THE MOVE-Netflix, J.B. Hunt, Arxis
U.S. STOCKS ON THE MOVE-Abbott, J.B. Hunt, Myseum
Hims rises as FDA considers broader peptides access; analysts see long-term win
U.S. STOCKS ON THE MOVE-Abbott, PepsiCo, Blue Owl
U.S. STOCKS ON THE MOVE-Hamilton Lane, Meta, Marsh
Hims & Hers rises on FDA move towards loosening restrictions on peptides
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron